Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1772231

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1772231

U.S. Allergy Diagnostics & Therapeutics Market Size, Share & Trends Analysis Report By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled, Drug, & Other Allergens), By Test Type, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Market Size & Trends:

The U.S. allergy diagnostics & therapeutics market size was valued at USD 10.86 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2030. The market is driven by the increasing prevalence of allergies among the population, and environmental factors such as increased pollution and lifestyle changes boost the demand for advanced solutions. The U.S. allergy diagnostics & therapeutics industry has witnessed a shift toward precision diagnostics. This evolution is fueled by groundbreaking innovations in molecular allergology and the widespread adoption of digital health tools.

Companies are actively expanding their allergy test portfolios, focusing on multiplex assays that enable the simultaneous detection of numerous allergens from a single patient sample. Furthermore, these diagnostic platforms are increasingly designed for seamless integration with Electronic Health Records (EHRs), a critical advancement that facilitates comprehensive patient data management and enhances clinical decision-making.

The industry is characterized by a high degree of innovation driven by ongoing research, technological advancements, and the development of more effective diagnostics and treatment options. In April 2025, Beckman Coulter Life Sciences announced the launch of its Next-Generation Basophil Activation Test (BAT). It is only for research purposes to expedite and improve allergy research.

The U.S. allergy diagnostics & therapeutics industry is also characterized by many new launches, strategic collaborations, and acquisitions among key players, emphasizing enhancing diagnostic accuracy and therapeutic efficacy. In January 2024, Inimmune Corporation and Intrommune Therapeutics announced a strategic partnership to develop a groundbreaking oral mucosal immunotherapy for peanut allergy.

U.S. Allergy Diagnostics & Therapeutics Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. allergy diagnostics & therapeutics market report based on type, allergen type, test type.

  • Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Diagnostics
    • Instruments
    • Consumables
    • Services
  • Therapeutics
    • Antihistamines
    • Decongestants
    • Corticosteroids
    • Mast Cell Stabilizers
    • Leukotriene Inhibitors
    • Nasal Anti-cholinergic
    • Immuno-modulators
    • Epinephrine
    • Immunotherapy
  • Allergen Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Food
    • Dairy Products
    • Poultry Product
    • Tree Nuts
    • Peanuts
    • Shellfish
    • Wheat
    • Soys
    • Other Food Allergens
  • Inhaled
  • Drug
  • Other Allergens
  • Test Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • In vivo test
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
  • In vitro test
Show more
Product Code: GVR-4-68040-650-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Allergen Type
    • 1.2.3. Test Type
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test outlook
    • 2.2.2. Allergen Type outlook
    • 2.2.3. Test Type outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Allergy Diagnostics & Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Allergy Diagnostics & Therapeutics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. U.S. Allergy Diagnostics & Therapeutics Market: Pipeline Analysis

Chapter 4. U.S. Allergy Diagnostics & Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. U.S. Allergy Diagnostics & Therapeutics Market: Type Movement Analysis
  • 4.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, By Type, 2018 To 2030 (USD Billion)
  • 4.4. Diagnostics
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Instruments
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Consumables
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.4. Services
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Therapeutics
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Antihistamines
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Decongestants
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.4. Corticosteroids
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.5. Mast Cell Stabilizers
      • 4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.6. Leukotriene Inhibitors
      • 4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.7. Nasal Anti - Cholinergic
      • 4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.8. Immuno - Modulators
      • 4.5.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.9. Epinephrine
      • 4.5.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.10. Immunotherapy
      • 4.5.10.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. Allergy Diagnostics & Therapeutics Market: Allergen Type Estimates & Trend Analysis

  • 5.1. Allergen Type Segment Dashboard
  • 5.2. U.S. Allergy Diagnostics & Therapeutics Market: Allergen Type Movement Analysis
  • 5.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, by Allergen Type, 2018 to 2030 (USD Billion)
  • 5.4. Food
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.2. Dairy Products
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.3. Poultry Product
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.4. Tree Nuts
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.5. Peanuts
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.6. Shellfish
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.7. Wheat
      • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.8. Soys
      • 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.9. Other Food Allergens
      • 5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Inhaled
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Drug
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. Other Allergens
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. U.S. Allergy Diagnostics & Therapeutics Market: Test Type Estimates & Trend Analysis

  • 6.1. Test Type Segment Dashboard
  • 6.2. U.S. Allergy Diagnostics & Therapeutics Market: Test Type Movement Analysis
  • 6.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, By Test Type, 2018 to 2030 (USD Billion)
  • 6.4. In vivo test
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.2. Skin Prick Test
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.3. Intradermal Test
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.4. Patch Test
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. In vitro test
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Thermo Fischer Scientific Inc.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Type benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Stallergenes Greer
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Type benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. HYCOR Biomedical
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Type benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Minaris Medical America, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Type benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Omega Diagnostics Ltd
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Type benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Lincoln Diagnostics, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Type benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Danaher Corporation
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Type benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Alcon Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Type benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. AbbVie Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Type benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Sanofi
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Type benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Pfizer Inc.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Type benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Merck & Co., Inc.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Type benchmarking
      • 7.4.12.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-650-0

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. allergy diagnostics & therapeutics market, by type, 2018 - 2030 (USD Billion)
  • Table 3 U.S. allergy diagnostics & therapeutics market, by allergen type, 2018 - 2030 (USD Billion)
  • Table 4 U.S. allergy diagnostics & therapeutics market, by test type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Allergy Diagnostics & Therapeutics market: market outlook
  • Fig. 10 U.S. Allergy Diagnostics & Therapeutics competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. Allergy Diagnostics & Therapeutics market driver impact
  • Fig. 16 U.S. Allergy Diagnostics & Therapeutics market restraint impact
  • Fig. 17 U.S. Allergy Diagnostics & Therapeutics market strategic initiatives analysis
  • Fig. 18 U.S. Allergy Diagnostics & Therapeutics market: type movement analysis
  • Fig. 19 U.S. Allergy Diagnostics & Therapeutics market: type outlook and key takeaways
  • Fig. 20 Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 21 Instrument market estimates and forecast, 2018 - 2030
  • Fig. 22 Consumable market estimates and forecast, 2018 - 2030
  • Fig. 23 Service market estimates and forecast, 2018 - 2030
  • Fig. 24 Therapeutics market estimates and forecast, 2018 - 2030
  • Fig. 25 Antihistamines market estimates and forecast, 2018 - 2030
  • Fig. 26 Decongestants market estimates and forecast, 2018 - 2030
  • Fig. 27 Corticosteroids market estimates and forecast, 2018 - 2030
  • Fig. 28 Mast cell stabilizers market estimates and forecast, 2018 - 2030
  • Fig. 29 Leukotriene inhibitors market estimates and forecast, 2018 - 2030
  • Fig. 30 Nasal anti - cholinergic market estimates and forecast, 2018 - 2030
  • Fig. 31 Immuno-modulators market estimates and forecast, 2018 - 2030
  • Fig. 32 Epinephrine market estimates and forecast, 2018 - 2030
  • Fig. 33 Immunotherapy market estimates and forecast, 2018 - 2030
  • Fig. 34 U.S. Allergy Diagnostics & Therapeutics market: allergen type movement analysis
  • Fig. 35 U.S. Allergy Diagnostics & Therapeutics market: allergen type outlook and key takeaways
  • Fig. 36 Food market estimates and forecasts, 2018 - 2030
  • Fig. 37 Dairy products market estimates and forecasts,2018 - 2030
  • Fig. 38 Poultry products market estimates and forecasts,2018- 2030
  • Fig. 39 Tree nuts market estimates and forecasts,2018 - 2030
  • Fig. 40 Peanuts market estimates and forecasts,2018 - 2030
  • Fig. 41 Shellfish market estimates and forecasts,2018 - 2030
  • Fig. 42 Soys market estimates and forecasts,2018 - 2030
  • Fig. 43 Other food allergens market estimates and forecasts,2018 - 2030
  • Fig. 44 Inhaled market estimates and forecasts,2018 - 2030
  • Fig. 45 Drug market estimates and forecasts,2018 - 2030
  • Fig. 46 Other allergens market estimates and forecasts,2018 - 2030
  • Fig. 47 U.S. Allergy Diagnostics & Therapeutics market: test type movement analysis
  • Fig. 48 U.S. Allergy Diagnostics & Therapeutics market: test type outlook and key takeaways
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030
  • Fig. 50 In vivo test market estimates and forecasts, 2018 - 2030
  • Fig. 51 Skin prick test market estimates and forecasts, 2018 - 2030
  • Fig. 52 Intradermal market estimates and forecasts, 2018 - 2030
  • Fig. 53 Patch test market estimates and forecasts,2018 - 2030
  • Fig. 54 In vitro test market estimates and forecasts,2018 - 2030
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!